During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

Patients treated in an outpatient setting who later required admission spent an average of 12.1 days in the hospital, ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

The immune system is made up of different types of cells, which have different roles in protecting the body from infection. One type of immune cell called a B cell creates antibodies that attack ...

Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

No two batches of cell therapy are identical, because each is made from a different originator cell. For process development scientists tasked with ensuring product quality, this lack of consistency ...

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Doctors at AIIMS, Delhi, are working on a cost-effective antibody-based adaptive cellular therapy for treating multiple myeloma, a form of blood cancer. This innovative approach aims to make advanced ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...